Deciphering how the GR forms oligomers—through the binding of several subunits—opens a crucial avenue for developing more ...

From industrial robots to self-driving cars, engineers face a common problem: keeping machines steady and predictable. When ...

This month, the White House announced that it is demolishing its East Wing in a bid to build US President Donald Trump’s new ...

Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...

SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage ...

Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...

Molecular biologists have long believed that the beginning of a gene launched the process of transcription—the process by ...

Phase 1 data of first-in-class NBD1 stabilizers, SION-719 and SION-451, demonstrated they were generally well tolerated and exceeded desired pharmacokinetic targets ...

An international research team led by a University of Ottawa Faculty of Medicine investigator has revealed ultra-detailed ...

Homeowners are embracing next-gen security solutions that integrate seamlessly with their lives – and their décor.

The broader adoption of artificial intelligence (AI) across enterprises has given rise to a new debate – should companies ...